BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8958379)

  • 21. Gastric Ga-67 uptake in patients with lymphoma.
    Nikpoor N; Drum DE; Aliabadi P
    Clin Nucl Med; 1995 Mar; 20(3):226-9. PubMed ID: 7750216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tl-201 and Ga-67 scintigraphy in non-Hodgkin's lymphoma.
    Mansberg R; Wadhwa SS; Mansberg V
    Clin Nucl Med; 1999 Apr; 24(4):239-42. PubMed ID: 10466518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary malignant lymphoma of the central nervous system by Ga-67 and TI-201 brain SPECT.
    Kosuda S; Aoki S; Suzuki K; Nakamura H; Nakamura O; Shidara N
    Clin Nucl Med; 1992 Dec; 17(12):961-4. PubMed ID: 1464174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
    Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
    Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Anderson JR; Harrison KA; Dalrymple GV; Byar K; Kessinger A; Armitage JO
    J Clin Oncol; 1996 Sep; 14(9):2473-9. PubMed ID: 8823325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative?
    Kaplan WD
    J Nucl Med; 1990 Mar; 31(3):369-71. PubMed ID: 2308009
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary non-Hodgkin's malignant lymphoma of the breast: long-term follow-up.
    Imai T; Shiga T
    Breast; 2004 Apr; 13(2):152-4. PubMed ID: 15019698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of FDG-PET in malignant lymphoma.
    Becherer A; Jaeger U; Szabo M; Kletter K
    Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of gallium 67 imaging in non-Hodgkin's lymphoma of the gastrointestinal tract.
    Kataoka M; Kawamura M; Tsuda T; Itoh H; Komatsu A; Tanada S; Iio A; Hamamoto K
    Eur J Nucl Med; 1990; 17(3-4):142-7. PubMed ID: 2279495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
    Howman-Giles R; Uren RF; Shaw PJ
    J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracardiac malignant lymphoma detected by gallium-67 citrate and thallium-201 chloride.
    Hamada S; Nishimura T; Hayashida K; Uehara T
    J Nucl Med; 1988 Nov; 29(11):1868-70. PubMed ID: 3183755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
    Rehm PK
    Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of gallium-67 citrate scintigraphy in gastro-intestinal malignant lymphoma].
    Kataoka M; Tsuda T; Kawamura M; Itoh H; Komatsu A; Mogami H; Tanada S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):155-63. PubMed ID: 2362795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between residual cancer and thymic hyperplasia in malignant non-Hodgkin's lymphoma with somatostatin receptor scintigraphy.
    Rettenbacher L; Galvan G
    Clin Nucl Med; 1994 Jan; 19(1):64-5. PubMed ID: 8137590
    [No Abstract]   [Full Text] [Related]  

  • 37. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after the treatment of Hodgkin's disease.
    Lee JD; Park CH; Griffith J; Vernick J
    J Nucl Med; 1992 Jun; 33(6):1183-5. PubMed ID: 1597736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scintigraphic evaluation with Tc-99m MDP and Ga-67 citrate in a case of pediatric T-cell lymphoma.
    Rivera-Rodriguez JE; Rodriguez AA; Turnbull GL; Moreno AJ
    Clin Nucl Med; 1992 Jan; 17(1):61-4. PubMed ID: 1544266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.